The effectiveness and safety of azvudine treatment in COVID‐19 patients with kidney disease based on a multicenter retrospective cohort study

The effectiveness and safety of azvudine treatment in COVID‐19 patients with kidney disease based on a multicenter retrospective cohort study

Abstract Kidney disease has been the main risk factor of poor prognosis for COVID‐19 patients. The effectiveness and safety of azvudine treatment in COVID‐19 patients with kidney disease have not been reported. Herein, we conducted a nine‐center and retrospective cohort study in China (ClinicalTrial...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Yu, Mengzhao Yang, Jia Yu, Daming Wang, Hong Luo, Ming Cheng, Shixi Zhang, Guotao Li, Ling Wang, Guowu Qian, Donghua Zhang, Silin Li, Zhigang Ren, Quancheng Kan
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:View
Subjects:
azvudine
COVID‐19
effectiveness
kidney disease
safety
Online Access:https://doi.org/10.1002/VIW.20240075
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/VIW.20240075

Similar Items